檢索結果 - Elizabeth Tuttle‐Newhall
- Showing 1 - 2 results of 2
-
1
-
2
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results 由 Gary Levy, Heinz Schmidli, Jeffrey D. Punch, Elizabeth Tuttle‐Newhall, David Mayer, P. Neuhaus, Didier Samuel, Björn Nashan, J. Klempnauer, Alan N. Langnas, Yvon Calmus, Xavier Rogiers, Michaël Abécassis, Richard B. Freeman, M. J. H. Sloof, John P. Roberts, Lutz Fischer
出版 2006Artigo
相關主題
Internal medicine
Medicine
Surgery
ABO blood group system
Adverse effect
Alternative medicine
Clinical endpoint
Dialysis
Everolimus
Gastroenterology
Intensive care medicine
Kidney transplantation
Liver function
Pathology
Pharmacology
Placebo
Randomized controlled trial
Renal function
Tolerability
Transplantation
Urology